[Safety and efficacy of inhaled ciclesonide in asthma].
Poor adherence to medications and other aspects of the treatment plan are described in patients with asthma, especially with adverse events concerning the upper respiratory and digestive tracts. Against this background a review is presented of current knowledge about the new class of glucocorticoids (ciclesonide).
Buczyłko
Krzysztof
K
Zakład Alergologii i Rehabilitacji Oddechowej Uniwersytetu Medycznego w Łodzi.
D000280:Administration, Inhalation; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy*; D006801:Humans; D011282:Pregnenediones / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D000893:Anti-Inflammatory Agents; D011282:Pregnenediones; C120481:ciclesonide